Marks Wealth’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,042
Closed -$14.3K 30
2025
Q2
$14.3K Buy
10,042
+18
+0.2% +$26 ﹤0.01% 22
2025
Q1
$14.9K Buy
10,024
+24
+0.2% +$38 0.01% 16
2024
Q4
$11.2K Hold
10,000
0.01% 16
2024
Q3
$9.47K Buy
+10,000
New +$12.6K ﹤0.01% 27

Other funds holding PGEN

Marks Wealth's PGEN Position: Q3 2025 in Review

Marks Wealth sold out of Precigen (PGEN) in Q3 2025, closing a stake of 10,042 shares — an estimated $14.3K sold.

Marks Wealth first reported a position in PGEN in Q3 2024 and held it in 4 quarters. The position peaked at $14.9K in Q1 2025. 167 funds tracked by Wall St. Rank hold PGEN as of Q3 2025.

  • Marks Wealth reported no remaining Precigen position as of Q3 2025 after selling out during the quarter.
  • Marks Wealth sold 10,042 Precigen shares in Q3 2025, an estimated $14.3K.
  • Marks Wealth first reported a position in Precigen in Q3 2024 and held it in 4 quarters.
  • Marks Wealth's Precigen position peaked at $14.9K in Q1 2025.
  • 167 funds tracked by Wall St. Rank held Precigen as of Q3 2025.

Based on Marks Wealth's 13F filing for Q3 2025, filed 28 Oct 2025.